Toronto Dominion Bank
VIVO

Toronto Dominion Bank’s Meridian Bioscience Inc VIVO Stock Holding History

Toronto Dominion Bank’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-167
Closed -$4K – 1568
2021
Q1 		$4K Buy
+167
New +$3.97K ﹤0.01% 1345
2019
Q3 		– Sell
-46
Closed – – 1736
2019
Q2 		$0 Buy
+46
New +$554 ﹤0.01% 1828

Other funds holding VIVO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Toronto Dominion Bank's VIVO Position: Q2 2021 in Review

Toronto Dominion Bank sold out of Meridian Bioscience Inc (VIVO) in Q2 2021, closing a stake of 167 shares — an estimated $4K sold.

Toronto Dominion Bank first reported a position in VIVO in Q2 2019 and held it in 2 quarters. The position peaked at $4K in Q1 2021. 189 funds tracked by Wall St. Rank hold VIVO as of Q2 2021.

  • Toronto Dominion Bank reported no remaining Meridian Bioscience Inc position as of Q2 2021 after selling out during the quarter.
  • Toronto Dominion Bank sold 167 Meridian Bioscience Inc shares in Q2 2021, an estimated $4K.
  • Toronto Dominion Bank first reported a position in Meridian Bioscience Inc in Q2 2019 and held it in 2 quarters.
  • Toronto Dominion Bank's Meridian Bioscience Inc position peaked at $4K in Q1 2021.
  • 189 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2021.

Based on Toronto Dominion Bank's 13F filing for Q2 2021, filed 10 Aug 2021.